Navigation Links
Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments
Date:2/26/2009

ng cash position, strong partners in GSK and Novartis, and multiple product opportunities to drive future value."

HGS also announced that it has repurchased $106.2 million principal amount of its outstanding convertible debt at a cost of $50.0 million in cash. The repurchase includes $82.9 million principal amount of the Company's 2 1/4% Convertible Subordinated Notes Due October 2011, and $23.3 million principal amount of the Company's 2 1/4% Convertible Subordinated Notes Due August 2012.

"We are pleased that we were able to capitalize on an opportunity to further strengthen our balance sheet by reducing our debt at reasonable prices," said Tim Barabe, Senior Vice President and Chief Financial Officer, HGS. "Our cash position remains strong and is sufficient to take us through the availability of Phase 3 data and the filing of marketing applications for our lead products, while also funding development of our product pipeline."

FINANCIAL RESULTS

HGS reported increased revenues of $48.2 million for the year ended December 31, 2008, compared with revenues of $41.9 million for the same period in 2007. Revenues for 2008 included $35.4 million recognized from the Albuferon agreement with Novartis, and $6.5 million in revenue recognized from the LymphoStat-B agreement with GSK.

The Company reported a net loss for 2008 of $244.9 million ($1.81 per share), compared with a net loss of $262.4 million ($1.95 per share) for 2007. The decreased net loss for 2008 was due primarily to a gain on the sale of CoGenesys stock of $32.5 million ($0.24 per share), partially offset by a decrease in investment income and a charge for impaired investments in debt issued by Lehman Brothers Holdings, Inc., of $6.3 million ($0.04 per share).

Net cash burn for 2008 totaled $244.8 million, compared with $179.9 million in 2007. The increase in net cash burn primarily reflected va
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile
2. GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA
3. FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE)
4. Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs
5. Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile
6. Mardil Inc. Advances Its Novel Cardiac Device to First-In-Human Trials for Mitral Valve Regurgitation
7. Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP
8. Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference
9. Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference
10. 2008 Human Research Protection Award Recipients Announced
11. USD 12.5 m Funding for the Development of Intercells Vaccine Patch System for Pandemic Influenza From U.S. Department of Health and Human Services (HHS)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... 2013  Aribex, Inc., manufacturer of the newly released ... new color option, black with gray trim, of the ... markets. The popular white with light blue trim Pro ... be available and both models can be purchased from ... http://photos.prnewswire.com/prnh/20130522/CL19573 ) "Dental offices are adding ...
(Date:5/22/2013)... May 22, 2013 Attorney Advertising -- Bronstein, ... on behalf of purchasers of the securities of ... AMAG -News).  The investigation focuses on whether the ... On May 22, 2013, Shares of ... after the company announced in regulatory filing that ...
(Date:5/22/2013)... and CAESAREA, Israel , May ... , New clinical data presented from the DEFLECT-I study ... Device reduces brain lesion volume during TAVR (Transcatheter Aortic ... Keystone Heart Scientific Advisory Board announces consensus on ... rising regarding the importance and need for cerebral protection ...
Breaking Medicine Technology:Aribex Unveils New Color of NOMAD Pro 2 2Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 2New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 3New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 4
... study published today in the,journal Current Medical ... superior to Cymbalta®,(duloxetine) in the acute treatment ... was at least as efficacious in,long-term treatment. ... reuptake inhibitor - ASRI) to duloxetine (a,serotonin ...
... - Both co-primary endpoints, Wake After Sleep Onset and ... Sleep, were met at both doses - Evotec to ... 10am EST) today , HAMBURG, Germany | OXFORD, England, ... today positive top-line,results from its first phase II clinical ...
Cached Medicine Technology:Cipralex demonstrates superiority to duloxetine for acute treatment,of depression in new study 2Cipralex demonstrates superiority to duloxetine for acute treatment,of depression in new study 3Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 2Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 3Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 4
(Date:5/23/2013)... New techniques in imaging of brain activity developed ... Neurological Institute, and his colleagues lead to improved ... combination of electroencephalogram (EEG) and functional magnetic resonance ... the areas generating epileptic seizures, giving neurosurgeons a ... if appropriate. These results were presented at ...
(Date:5/23/2013)... , , WEDNESDAY, May 22 (HealthDay News) -- The success of ... born with a serious airway malformation sheds light on new ... A report in the May 23 New England Journal ... At first, the baby born five weeks early seemed ... eating when he was 6 weeks old. Just two weeks ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 According to ... [Converged Services; Policy Management; Subscriber Data Management (SDM); Telecom ... Forecasts and Analysis (2013 – 2018)", published by MarketsandMarkets, ... by 2018 at a CAGR of 9.15% from 2013 ... Market Data Tables , 84 Figures , ...
(Date:5/23/2013)... Located at 22343 La Palma Ave. #125, fitness ... Grand Opening Family Fun Charity event on May 11, 2013 ... physical fitness. Sponsored by many different vendors like Chick-fil-a and ... Grand Opening featured mini boot camp sessions and raffled off ... Yorba Linda fitness center has to offer. ...
(Date:5/23/2013)... In Florida, residents have not been hit ... however, that Florida’s good luck will continue, warns Rick Knabb, ... he encourages residents, it is important to prepare as if ... predicting there to be a 50-percent chance that a major ... season lasting from June 1 to November 30 in Florida, ...
Breaking Medicine News(10 mins):Health News:New imaging techniques used to help patients suffering from epilepsy 2Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 2Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 3Health News:Service Delivery Platform (SDP) Market Is Growing at a CAGR of 9.15% & to Reach $6.94 Billion by 2018 - New Report by MarketsandMarkets 2Health News:Service Delivery Platform (SDP) Market Is Growing at a CAGR of 9.15% & to Reach $6.94 Billion by 2018 - New Report by MarketsandMarkets 3Health News:Yorba Linda Personal Trainer Celebrates Fit Body Boot Camp Yorba Linda Grand Opening by Hosting a Family Fun Charity Event 2Health News:Yorba Linda Personal Trainer Celebrates Fit Body Boot Camp Yorba Linda Grand Opening by Hosting a Family Fun Charity Event 3Health News:As Hurricane Season Nears, Skylake Insurance Encourages Florida Residents To Prepare Early For Safety 2
... America,s Future co-director Roger Hickey , Economic Policy ... Economic and Policy Research co-director Dean Baker ... President Obama ,s summit today on the nation,s future ... LAWRENCE MISHEL We applaud President ...
... Feb. 23 The non-profit LENA(TM) Foundation, which develops ... language disorders, has released two case studies showing how ... autism treatment. The LENA software enables the clinician ... turns at 5-minute and hourly intervals over the course ...
... eFoodSafety.com, Inc., (OTC Bulletin Board: EFSF) an emerging ... dermatology, environmental and nutraceutical products, today announced that Martin ... future Chairman and CEO of eFoodSafety.com, has purchased stock ... total of 100,000 shares in the open market on ...
... in Phoenix to Focus on Catheter Reduction and ... SEGUNDO, Calif., Feb 23 DaVita Inc., a ... 2009 Clinical Priorities to its partnering nephrologists during ... of the largest gatherings of nephrologists of the ...
... Practices provide guidance for healthcare systems in ... and community engagementWASHINGTON, Feb. 23 The ... to improving healthcare quality, has endorsed 45 ... care that is culturally appropriate and patient-centered. ...
... 23 Vanda Pharmaceuticals Inc. (Nasdaq: ... statement regarding two letters sent to Vanda by Tang Capital ... its intent to, among other things, nominate two directors to ... and submit proposals at the 2009 Annual Meeting to amend ...
Cached Medicine News:Health News:Progressive Leaders at White House Summit Today Underscore Need for Health Care Reform 2Health News:LENA Foundation Technology Measures Effectiveness of Autism Therapy 2Health News:LENA Foundation Technology Measures Effectiveness of Autism Therapy 3Health News:eFoodSafety.com Announces Open Market Stock Purchase by Management 2Health News:DaVita Releases Top Clinical Priorities for 2009 2Health News:DaVita Releases Top Clinical Priorities for 2009 3Health News:National Quality Forum Endorses Guidelines to Reduce Disparities in Healthcare and Make Care Patient-Centered and Culturally Appropriate 2Health News:National Quality Forum Endorses Guidelines to Reduce Disparities in Healthcare and Make Care Patient-Centered and Culturally Appropriate 3Health News:Vanda Pharmaceuticals Responds to Announcement and Filing by a Group Led by Tang Capital Partners, LP 2Health News:Vanda Pharmaceuticals Responds to Announcement and Filing by a Group Led by Tang Capital Partners, LP 3Health News:Vanda Pharmaceuticals Responds to Announcement and Filing by a Group Led by Tang Capital Partners, LP 4Health News:Vanda Pharmaceuticals Responds to Announcement and Filing by a Group Led by Tang Capital Partners, LP 5Health News:Vanda Pharmaceuticals Responds to Announcement and Filing by a Group Led by Tang Capital Partners, LP 6
... The Stereo Cube is used to diagnose ... without the use of polarized glasses. The ... of binocularity, stereopsis, visual attention, form and depth ... of 850 to 450 seconds of arc and ...
... created to simplify stereopsis screening in children. It ... cylindrical gratings. Lang Stereotest II measures disparities: Moon ... 600 seconds of arc plus monocularly visible star. ... dots are smaller and less dense. This disparity ...
... provide accurate measurement of stereopsis. These ... polarized glasses. The original comes with ... a thin plastic frame with plastic ... new P/N 4465 Polycarbonate polarized hard ...
... stereo test was developed to test for both ... employs the more reliable red/green glasses to ... not dependent on polarizing spectacles which can be ... an attractive image of a butterfly which makes ...
Medicine Products: